 |
BioWorld-Insight-2002-11-18
Stock Winners and Losers For The Week
Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: October 2002
No Abstract
Cash-Positive Companies Have Best Chance Of Impressing VCs
Walk into any funding firm and you will see mountains of papers summarizing this company's dream and that company's vision. (BioWorld Financial Watch)